105 related articles for article (PubMed ID: 8094619)
41. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
Mikami Y; Davis JG; Dobashi K; Dougall WC; Myers JN; Brown VI; Greene MI
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7335-9. PubMed ID: 1354355
[TBL] [Abstract][Full Text] [Related]
42. Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily.
Hung CF; Penning TM
Mol Endocrinol; 1999 Oct; 13(10):1704-17. PubMed ID: 10517672
[TBL] [Abstract][Full Text] [Related]
43. Polymorphic changes of cell phenotype caused by elevated expression of an exogenous NEU proto-oncogene.
Tarakhovsky AM; Resnikov M; Zaichuk T; Tugusheva MV; Butenko ZA; Prassolov VS
Oncogene; 1990 Mar; 5(3):405-10. PubMed ID: 1969137
[TBL] [Abstract][Full Text] [Related]
44. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
45. Effects of oncogenes on the resistance to cis-diamminedichloroplatinum(II) and metallothionein gene expression.
Yamada-Okabe T; Yamada-Okabe H; Kashima Y; Doi R
Toxicol Appl Pharmacol; 1995 Aug; 133(2):233-8. PubMed ID: 7645018
[TBL] [Abstract][Full Text] [Related]
46. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of the neu oncogene in mouse liver and pancreatic cell lines.
Yan DH; Marin MC; Hung MC
Biochem Biophys Res Commun; 1992 Jul; 186(1):363-70. PubMed ID: 1352968
[TBL] [Abstract][Full Text] [Related]
48. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer.
Ho IC; Bhat NK; Gottschalk LR; Lindsten T; Thompson CB; Papas TS; Leiden JM
Science; 1990 Nov; 250(4982):814-8. PubMed ID: 2237431
[TBL] [Abstract][Full Text] [Related]
49. Regulation of troponin T gene expression in chicken fast skeletal muscle: involvement of an M-CAT-like element distinct from the standard M-CAT.
Watanabe T; Takemasa T; Yonemura I; Hirabayashi T
J Biochem; 1997 Feb; 121(2):212-8. PubMed ID: 9089392
[TBL] [Abstract][Full Text] [Related]
50. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
51. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
52. An extra cysteine proximal to the transmembrane domain induces differential cross-linking of p185neu and p185neu.
Cao H; Bangalore L; Dompé C; Bormann BJ; Stern DF
J Biol Chem; 1992 Oct; 267(28):20489-92. PubMed ID: 1356980
[TBL] [Abstract][Full Text] [Related]
53. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene.
Ktistaki E; Lacorte JM; Katrakili N; Zannis VI; Talianidis I
Nucleic Acids Res; 1994 Nov; 22(22):4689-96. PubMed ID: 7984419
[TBL] [Abstract][Full Text] [Related]
55. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
Sottocornola E; Berra B; Colombo I
Biochim Biophys Acta; 2003 Dec; 1635(2-3):55-66. PubMed ID: 14729068
[TBL] [Abstract][Full Text] [Related]
56. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
Drebin JA; Link VC; Stern DF; Weinberg RA; Greene MI
Cell; 1985 Jul; 41(3):697-706. PubMed ID: 2860972
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
60. Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome.
Luster TA; Rizzino A
Gene; 2003 Dec; 323():163-72. PubMed ID: 14659890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
